NASDAQ <$500M

NASDAQ IR Firm for Companies Under $500M Market Cap

NASDAQ has ~3,700 listed companies. Roughly 2,400 of them — 65% — are under $500M market cap. Legacy IR firms overwhelmingly serve the other 35%. AxonIR is the AI-native IR firm purpose-built for the underserved majority of NASDAQ — starting at $750/month.

The NASDAQ Sub-$500M Reality

You compete against Apple and Microsoft for attention on the same exchange. Algorithmic traders treat you identically — NLP-scoring your filings, consuming structured data feeds, triggering on sentiment shifts. Your IR firm doesn't see any of it.

  • Nasdaq continued listing standards — $1.00 bid, $2.5M/$5M/$10M equity tiers
  • Under $500M market cap = thin sell-side coverage, if any
  • 70% of Nasdaq small-cap trading is algorithmic — structured signals matter
  • Legacy IR firms charge $8K–$15K for service designed around human roadshows
  • Short-seller attacks cluster on Nasdaq small/micro-caps due to liquidity dynamics
  • Cross-listing with ADRs, SPAC legacies, biotech — Nasdaq has the most diverse small-cap mix

AI-Native IR for NASDAQ Companies

01Nasdaq-Tuned NLP Scoring

Our NLP models are calibrated on Nasdaq small-cap filing patterns — the highest-frequency filer cohort. Scoring accuracy benchmarked against actual post-filing price moves.

02Nasdaq Listing Compliance

Continuous tracking of Rule 5550 (Capital Market) and Rule 5450 (Global Market) standards — bid price, stockholders' equity, public float, MVLS.

03Algo Signal Distribution

Structured press release distribution to Nasdaq Data Link directly, plus Benzinga Pro, AlphaSense, StockTwits API.

04Real-Time Algo Score Tracking

See how algos scored your latest filing within minutes of EDGAR release. Compare against prior quarters and peer companies.

NASDAQ IR Pricing

Month-to-month. No annual lock-in. One-time $5,000 setup fee. Cancel with 30 days notice.

Launch

$750/mo

Entry tier for nano/micro-caps

  • NLP filing scoring
  • Monthly algo report
  • Basic social sentiment
  • Press release review
Popular

Growth

$1,500/mo

Most popular for micro-caps

  • Everything in Launch
  • Algo signal broadcasting
  • Conference selection + 1x1s
  • Weekly sentiment dashboard
  • Short-seller early warning

Scale

$2,500/mo

For active small-caps

  • Everything in Growth
  • Dedicated IR analyst
  • Activist threat prediction
  • Perception studies
  • Earnings call prep + NLP scoring

Enterprise

$4,000/mo

Full-service replacement for $10K+ firms

  • Everything in Scale
  • Crisis response retainer
  • Bespoke NLP research
  • Board-level reporting
  • Priority incident response

NASDAQ IR Firm Comparison

FirmPricingFocusAI Capabilities
AxonIR$750–$4,000/moNasdaq under $500M + AI12 native capabilities
ICR$8,000–$20,000/moNasdaq mid/smallNone
KCSA Strategic$7,000–$15,000/moNasdaq + AmplifIR toolSoftware, not NLP
Gateway Group$10,000+/moAll exchangesNone
Crescendo$5,000/mo minNasdaq micro/smallNone
MZ Group$7,000–$15,000/moCross-border NasdaqNone

Why NASDAQ Sub-$500M Companies Need Purpose-Built IR

NASDAQ is a paradox. On one hand, it is home to Apple, Microsoft, Nvidia, and Tesla — the largest public companies in the world by market cap. On the other hand, it is home to roughly 2,400 companies under $500M market cap that compete on the same exchange, in the same order books, against those same megacaps for algorithmic attention. When a hedge fund's NLP model scores your 10-Q, it does not know or care that you are a $200M biotech instead of a $2.5T AI titan. You get the same treatment, the same speed, the same scoring rubric.

The practical consequence is that sub-$500M Nasdaq companies need IR infrastructure that is calibrated for the world of algorithmic and passive flows, because that is what actually drives their daily volume. Approximately 70% of trading in Nasdaq small-caps originates from algorithmic or passive sources. Press releases that are not structured for algo consumption, filings that have not been pre-scored for NLP signals, and earnings calls that have not been prepared with sentiment modeling in mind are all leaving alpha on the table — either helping you or hurting you, but invisibly.

Legacy IR firms serving Nasdaq companies were built in an era when sell-side analyst cultivation was the central IR job. That era is largely over for sub-$500M Nasdaq companies. You cannot buy your way to sell-side coverage at that size. What you can do is make yourself algorithmically visible and sentiment-positive, so that the buy-side quants running the modern Nasdaq flow engine find you, score you correctly, and include you in their universe.

AxonIR was built for the underserved majority of NASDAQ. Our NLP models are trained and continuously benchmarked against actual Nasdaq small-cap filing-to-price-move correlations. Our algo signal distribution includes direct Nasdaq Data Link structured feeds. Our listing compliance monitoring is calibrated to Nasdaq Capital Market and Global Market rules (5550, 5450), not generic exchange rules. And our pricing reflects the fact that a $250M Nasdaq small-cap cannot justify spending 0.5% of market cap annually on IR.

The net for Nasdaq-listed CFOs: if your current IR firm cannot tell you what NLP score your last 10-Q received, where your structured signals are being distributed, and how many days of compliance cushion you have on Rule 5550 — you are running IR with 2015 tooling on a 2026 exchange. AxonIR exists to close that gap.

Frequently Asked Questions

How many Nasdaq companies are under $500M market cap?

+

Of approximately 3,700 Nasdaq-listed companies, roughly 65% (2,400+) have market caps under $500M. This cohort includes Nasdaq Capital Market and lower tiers of Nasdaq Global Market, and it is the most underserved segment by legacy IR firms.

What Nasdaq listing standards does AxonIR track?

+

AxonIR continuously monitors Rule 5550 (Nasdaq Capital Market continued listing) and Rule 5450 (Nasdaq Global Market) standards — minimum bid price ($1.00), stockholders' equity ($2.5M/$5M/$10M tiers), public float, market value of listed securities, and MVPHS. Included at all tiers with 30/60/90-day deficiency alerts.

Does AxonIR work with Nasdaq-listed biotechs and SPACs?

+

Yes — both are within our sweet spot. Biotechs benefit disproportionately from short-seller early warning (highest-attack sector). SPACs and de-SPAC companies benefit from algo signal rehabilitation and post-merger NLP scoring to stabilize sentiment.

How is AxonIR different from KCSA's AmplifIR platform?

+

AmplifIR is a software tool — you pay for software access plus separate advisory time. AxonIR bundles software + advisory in one flat rate, and our NLP scoring is 6-dimensional with section-level granularity versus AmplifIR's broader scorecard.

IR Built for NASDAQ Under $500M

Get a free algo score on your latest Nasdaq filing.